why choose us

First received: August 05, 2022

Clinical Trial: A Study of LY3873862 in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Single Ascending and Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3873862 in Healthy Participants

Brief Summary: The main purpose of this study is to evaluate the safety and tolerability of LY3873862 when administered either in single or multiple doses in healthy participants.The study will also assess how fast LY3873862 gets into the blood stream and how long it takes the body to remove it.The study is open to healthy participants.The study will last up to approximately 58, 72, and 72 days for Part A, B, and C, respectively.

Read more